Physician profile
Tyler Kimball Wright
NPI 1679140891
$379.60
in general payments reported to CMS, 2019-2025
14 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.56 · 2023: $30.30 · 2024: $143 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $70.25 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.26 | 2024-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $46.48 | 2024-2025 | Spravato |
| Hologic Sales and Service, LLC | $43.87 | 2024 | Thinprep 2000 Processor, Third Wave, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $31.67 | 2024-2025 | |
| Lilly USA, LLC | $19.25 | 2025 | Mounjaro, Zepbound |
| Paratek Pharmaceuticals, INC. | $16.07 | 2023 | Nuzyra |
| Exact Sciences Corporation | $16.00 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $15.77 | 2021 | |
| Amgen INC. | $15.36 | 2024 | Repatha, Otezla |
| Mannkind Corporation | $14.61 | 2024 | |
| Neurocrine Biosciences, INC. | $14.23 | 2023 | Ingrezza, Ongentys |
| Kowa Pharmaceuticals America, INC. | $13.99 | 2025 | Zoryve |
| Amarin Pharma, INC. | $13.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.